Life Changing Daily Pill that Fights Cancer and Autoimmune Diseases
Invest Now for a Limited Time

Trethera COO Cary Talbot presents “The Waterfall,” the company’s structured product development strategy for TRE-515. This narrated presentation explains how a single drug candidate can support multiple development paths and generate unique revenue streams.

Topics covered include:

  • TRE-515 as a monotherapy or in combination for solid tumors
  • Opportunities in oncology and autoimmune disease indications
  • Strategic milestones and checkpoints across the development lifecycle
  • Trethera’s vision for translating science into marketable therapies

This session provides an inside look at how Trethera is driving innovation, managing risk, and positioning TRE-515 for multiple therapeutic opportunities.